Literature DB >> 11254726

Evidence for a role for SAM68 in the responses of human neutrophils to ligation of CD32 and to monosodium urate crystals.

C Gilbert1, F Barabé, E Rollet-Labelle, S G Bourgoin, S R McColl, B B Damaj, P H Naccache.   

Abstract

SAM68 (Src-associated in mitosis 68 kDa) is a member of the signal transduction of activator RNA novel gene family coding for proteins postulated to be involved in signal transduction and activation of RNA. It has been implicated through its phosphorylation status in the control of the transition from the G(1) to the S phases during mitosis. However, the implication and role of SAM68 in nonproliferative cells are unknown. The present study was initiated to examine the role of SAM68 in the phagocytic responses of the terminally differentiated human neutrophils. The results obtained show that SAM68 is present in human neutrophils and that it is tyrosine phosphorylated in response to stimulation by monosodium urate crystals or by ligation of CD32. Stimulation of neutrophils by these agonists decreases the association of SAM68 with Sepharose-conjugated poly-U beads. Additionally, the amount of immunoprecipitable SAM68 was modulated differentially after stimulation by monosodium urate crystals or by CD32 engagement indicating that the posttranslational modifications and/or protein associations of SAM68 induced by these two agonists differed. The results of this study provide evidence for an involvement of SAM68 in signal transduction by phagocytic agonists in human neutrophils and indicate that SAM68 may play a role in linking the early events of signal transduction to the posttranscriptional modulation of RNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254726     DOI: 10.4049/jimmunol.166.7.4664

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Sam68 is tyrosine phosphorylated and recruited to signalling in peripheral blood mononuclear cells from HIV infected patients.

Authors:  S Najib; J Rodríguez-Baño; M J Ríos; M A Muniain; R Goberna; V Sánchez-Margalet
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  Human immunodeficiency virus type 1 replication in dendritic cell-T-cell cocultures is increased upon incorporation of host LFA-1 due to higher levels of virus production in immature dendritic cells.

Authors:  Caroline Gilbert; Réjean Cantin; Corinne Barat; Michel J Tremblay
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

3.  Sam68 relocalization into stress granules in response to oxidative stress through complexing with TIA-1.

Authors:  Jorge Henao-Mejia; Johnny J He
Journal:  Exp Cell Res       Date:  2009-07-14       Impact factor: 3.905

4.  Common and Rare Variants Genetic Association Analysis of Circulating Neutrophil Extracellular Traps.

Authors:  Samantha J Donkel; Eliana Portilla Fernández; Shahzad Ahmad; Fernando Rivadeneira; Frank J A van Rooij; M Arfan Ikram; Frank W G Leebeek; Moniek P M de Maat; Mohsen Ghanbari
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

5.  Sam68 contributes to intestinal inflammation in experimental and human colitis.

Authors:  Wendy A Goodman; Shrikanth C Basavarajappa; Angela R Liu; Franklin D Staback Rodriguez; Tailor Mathes; Parameswaran Ramakrishnan
Journal:  Cell Mol Life Sci       Date:  2021-10-24       Impact factor: 9.207

6.  Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases.

Authors:  Marina Tiemi Shio; Marina Tiemi Shio; Stephanie C Eisenbarth; Myriam Savaria; Adrien F Vinet; Marie-Josée Bellemare; Kenneth W Harder; Fayyaz S Sutterwala; D Scott Bohle; Albert Descoteaux; Richard A Flavell; Martin Olivier
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

7.  Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome.

Authors:  Benedikt Asbach; Christine Ludwig; Kalle Saksela; Ralf Wagner
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.